DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY
Clinical trials for DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY trials appear
Sign up with your email to follow new studies for DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo treatment aims to boost Cancer-Killing power of CAR-T therapy
Disease control Not yet recruitingThis early-stage study is testing whether giving a short course of targeted radiation therapy along with an oral antibiotic (vancomycin) is safe and feasible for patients with aggressive B-cell lymphomas before they receive standard CAR-T cell therapy. The goal is to see if this …
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New immune therapy tested to boost stem cell transplant success for tough lymphomas
Disease control Not yet recruitingThis study is testing a new immune-based drug called glofitamab for adults with an aggressive type of lymphoma (DLBCL) that has returned or not responded to initial chemotherapy. The goal is to see if using glofitamab before and/or after a stem cell transplant can help control th…
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY
Phase: PHASE2 • Sponsor: American University of Beirut Medical Center • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC